"Carbamazepine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
| Descriptor ID |
D002220
|
| MeSH Number(s) |
D03.633.300.240.127
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Carbamazepine".
Below are MeSH descriptors whose meaning is more specific than "Carbamazepine".
This graph shows the total number of publications written about "Carbamazepine" by people in this website by year, and whether "Carbamazepine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 4 | 0 | 4 |
| 2003 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbamazepine" by people in Profiles.
-
Bakkaloglu S, Ersan M, Karanfil T, Apul OG. Effect of superfine pulverization of powdered activated carbon on adsorption of carbamazepine in natural source waters. Sci Total Environ. 2021 Nov 01; 793:148473.
-
Goodman CW, Brett AS. Race and Pharmacogenomics-Personalized Medicine or Misguided Practice? JAMA. 2021 Feb 16; 325(7):625-626.
-
Lee D, Kalu U, Halford JJ, Biton V, Cloyd J, Klein P, Bekersky I, Peng G, Dheerendra S, Tolbert D. Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials. Epilepsia. 2015 Jun; 56(6):906-14.
-
Lyons MJ, Duron R, Molinero I, Sangiuolo F, Holden KR. Novel CLCN1 mutation in carbamazepine-responsive myotonia congenita. Pediatr Neurol. 2010 May; 42(5):365-8.
-
Post RM, Ketter TA, Uhde T, Ballenger JC. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. CNS Drugs. 2007; 21(1):47-71.
-
Syn WK, Naisbitt DJ, Holt AP, Pirmohamed M, Mutimer DJ. Carbamazepine-induced acute liver failure as part of the DRESS syndrome. Int J Clin Pract. 2005 Aug; 59(8):988-91.
-
Book SW, Myrick H. Novel anticonvulsants in the treatment of alcoholism. Expert Opin Investig Drugs. 2005 Apr; 14(4):371-6.
-
Beydoun A, Sachdeo RC, Kutluay E, McCague K, D'Souza J. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia. 2003 Sep; 44(9):1160-5.
-
Varon D, Pritchard PB, Wagner MT, Topping K. Transient Kluver-Bucy syndrome following complex partial status epilepticus. Epilepsy Behav. 2003 Jun; 4(3):348-51.
-
Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003 Apr; 4(2):175-80.